Psychedelic experience sources of some psychedelic drugs such as ayahuasca and mescaline-containing cacti are sometimes referred to as "plant teachers". Similarly, in a follow-up to the psilocybin and mysticism study at Johns Hopkins, researchers observed that psilocybin: "occasions personally and spiritually significant mystical experiences that predict long-term changes in behaviors, attitudes and values". Psychedelic experience includes the full range of mystical or religious experiential phenomena. Two scientific studies have concluded that psilocybin (a typical psychedelic compound that occurs naturally in psilocybin mushrooms) reliably triggers mystical-type experiences. The more recent study at Johns Hopkins University identified mystical experiences by means of several questionnaires
NBOMe-mescaline in the list of scheduled controlled substances in the USA. It is therefore not scheduled at the federal level in the United States, but it is possible that NBOMe-mescaline could legally be considered an analog of mescaline, and therefore sales or possession could potentially be prosecuted under the Federal Analogue Act. NBOMe-mescaline NBOMe-mescaline or mescaline-NBOMe is a synthetic substituted phenethylamine. It is a partial agonist of serotonin receptors with a 5-HT pKi originally reported as 7.3 (i.e. Ki of approximately 50nM), though more modern techniques assayed it as 140nM at 5-HT and 640nM at 5-HT, making it one of the